Chemours
418 hedge funds and large institutions have $1.96B invested in Chemours in 2019 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 116 increasing their positions, 153 reducing their positions, and 114 closing their positions.
0.87% more ownership
Funds ownership: 79.42% → 80.3% (+0.87%)
14% less funds holding
Funds holding: 488 → 418 (-70)
24% less repeat investments, than reductions
Existing positions increased: 116 | Existing positions reduced: 153
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
37% less capital invested
Capital invested by funds: $3.12B → $1.96B (-$1.16B)
60% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 114
71% less call options, than puts
Call options by funds: $25.9M | Put options by funds: $90.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
+$81.3M |
| 2 |
SC
Sessa Capital
New York
|
+$75.8M |
| 3 |
GC
Greenlight Capital
New York
|
+$44.9M |
| 4 |
MWA
Marshall Wace Asia
Central,
Hong Kong
|
+$30.5M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TP
Third Point
New York
|
-$105M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$33.2M |
| 3 |
BlackRock
New York
|
-$28.4M |
| 4 |
State Street
Boston,
Massachusetts
|
-$27.6M |
| 5 |
Goldman Sachs
New York
|
-$21.2M |
CC Hedge Fund Activity: Q3 2019 in Review
418 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q3 2019, worth a combined $1.96B — down 37% from $3.12B a quarter earlier.
Sellers outnumbered buyers: 114 funds closed out of CC and 46 opened new positions — a net loss of 68 holders — while 153 trimmed existing stakes and 116 added.
The largest buyer was Norges Bank, adding an estimated $81.3M. The largest seller was Third Point, exiting entirely with an estimated $105M sold.
- 418 institutional investors held Chemours (CC) as of Q3 2019, down from 488 in Q2 2019.
- Funds reported $1.96B of Chemours stock for Q3 2019, down 37% quarter-over-quarter.
- 46 funds opened new Chemours positions in Q3 2019 and 114 closed out, a net change of -68 holders.
- The largest Chemours buyer in Q3 2019 was Norges Bank, an estimated $81.3M added.
- The largest Chemours seller in Q3 2019 was Third Point, an estimated $105M sold.
Based on aggregated 13F filings for Q3 2019.